Yohei Okada

8.8k citations

69 papers · 5.6k indexed · 3 hit papers · h-index 32

Developmental Neuroscience top 0.2%
- Neurogenesis and neuroplasticity mechanisms 15
Genetics top 1%
- Neurogenetic and Muscular Disorders Research 8
- Mesenchymal stem cell research 7
Cellular and Molecular Neuroscience top 1%
- Genetic Neurodegenerative Diseases 8
Molecular Biology top 1%
- Pluripotent Stem Cells Research 27
- CRISPR and Genetic Engineering 10
- RNA Research and Splicing 7
- Muscle Physiology and Disorders 6
Aging top 5%

Co-authors: Hideyuki Okano Shinya Yamanaka Masaya Nakamura Wado Akamatsu Takuya Shimazaki Gen Sobue Satoshi Nori Yoshiaki Toyama
Cited by: Developmental Neuroscience Genetics Cellular and Molecular Neuroscience
Partner nations: Japan United States Germany

In The Last Decade

Yohei Okada

66 papers receiving 5.5k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2011 Grafted human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice
2011 Modeling familial Alzheimer's disease with induced pluripotent stem cells
2009 Variation in the safety of induced pluripotent stem cell lines

Peers

Countries citing papers authored by Yohei Okada

Since Specialization

Citations

This map shows the geographic impact of Yohei Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohei Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohei Okada more than expected).

Fields of papers citing papers by Yohei Okada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohei Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohei Okada. The network helps show where Yohei Okada may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yohei Okada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yohei Okada Line = papers co-authored together Yohei Okada links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment Kentaro Maeda,Tomoki Hirunagi,Kentaro Sahashi,Yukiko Kamiya,Madoka Iida,Kenji Sakakibara,Kazunari Onodera,Manabu Ohyama,Yohei Okada,Hideyuki Okano,Hiroyuki Asanuma,Masahisa Katsuno	2025	0
2	Construction of contractile human iPSC-derived skeletal muscle tissues on 96-well scale microdevices Shinya Nakamura,Y. Kamei,Aki Matsushima,Kazuki Yamamoto,Hirokazu Akiyama,Muhammad Rashid,Yohei Okada,Tomoya Uchimura,Hidetoshi Sakurai,Hiroyuki Honda,Kazunori Shimizu	2025	0
3	Evaluation of fatigue, load and the quality of chest compressions by bystanders in hot and humid environments Haruka Takahashi,Kensuke Suzuki,Yohei Okada,Satoshi Harada,Hiroyuki Yokota,Marcus Eng Hock Ong,Satoo Ogawa	2024	1
4	Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS Tomoki Hirunagi,Kentaro Sahashi,Kiyoshi Tachikawa,Angel Leu,Michelle Nguyen,Rajesh Mukthavaram,Priya Karmali,Padmanabh Chivukula,Genki Tohnai,Madoka Iida,Kazunari Onodera,Manabu Ohyama,Yohei Okada,Hideyuki Okano,Masahisa Katsuno	2021	27
5	Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy Madoka Iida,Kentaro Sahashi,Naohide Kondo,Hideaki Nakatsuji,Genki Tohnai,Yutaka Tsutsumi,Seiya Noda,Ayuka Murakami,Kazunari Onodera,Yohei Okada,Masahiro Nakatochi,Yuka Tsukagoshi Okabe,Shinobu Shimizu,Masaaki Mizuno,Hiroaki Adachi,Hideyuki Okano,Gen Sobue,Masahisa Katsuno	2019	15
6	Long-Term Safety Issues of iPSC-Based Cell Therapy in a Spinal Cord Injury Model: Oncogenic Transformation with Epithelial-Mesenchymal Transition Satoshi Nori,Yohei Okada,Soraya Nishimura,Takashi Sasaki,Go Itakura,Yoshiomi Kobayashi,François Renault-Mihara,Atsushi Shimizu,Ikuko Koya,Rei Yoshida,Jun Kudoh,Masato Koike,Yasuo Uchiyama,Eiji Ikeda,Yoshiaki Toyama,Masaya Nakamura,Hideyuki Okano	2015	164
7	Involvement of ER Stress in Dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 Missense Mutations Shown by iPSC-Derived Oligodendrocytes Yuko Numasawa-Kuroiwa,Yohei Okada,Shinsuke Shibata,Noriyuki Kishi,Wado Akamatsu,Masanobu Shoji,Atsushi Nakanishi,Manabu Oyama,Hitoshi Osaka,Ken Inoue,Kazutoshi Takahashi,Shinya Yamanaka,Kenjiro Kosaki,Takao Takahashi,Hideyuki Okano	2014	97
8	Perlecan is required for FGF-2 signaling in the neural stem cell niche Aurélien Kerever,F. Mercier,Risa Nonaka,Susana de Vega,Yuka Oda,Bernard Zalc,Yohei Okada,Nobutaka Hattori,Yoshihiko Yamada,Eri Arikawa‐Hirasawa	2014	67
9	A human Dravet syndrome model from patient induced pluripotent stem cells Norimichi Higurashi,Taku Uchida,Christoph Lossin,Yoshio Misumi,Yohei Okada,Wado Akamatsu,Yoichi Imaizumi,Bo Zhang,Kazuki Nabeshima,Masayuki Mori,Shutaro Katsurabayashi,Yukiyoshi Shirasaka,Hideyuki Okano,Shinichi Hirose	2013	97
10	Establishment of Induced Pluripotent Stem Cells from Centenarians for Neurodegenerative Disease Research Takuya Yagi,Arifumi Kosakai,Daisuke Ito,Yohei Okada,Wado Akamatsu,Yoshihiro Nihei,Akira Nabetani,Fuyuki Ishikawa,Yasumichi Arai,Nobuyoshi Hirose,Hideyuki Okano,Norihiro Suzuki	2012	66
11	Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity Yoshiomi Kobayashi,Yohei Okada,Go Itakura,Hiroki Iwai,Soraya Nishimura,Akimasa Yasuda,Satoshi Nori,Keigo Hikishima,Tsunehiko Konomi,Kanehiro Fujiyoshi,Osahiko Tsuji,Yoshiaki Toyama,Shinya Yamanaka,Masaya Nakamura,Hideyuki Okano	2012	227
12	RNA-Binding Protein Musashi1 Modulates Glioma Cell Growth through the Post-Transcriptional Regulation of Notch and PI3 Kinase/Akt Signaling Pathways Jun Muto,Takao Imai,Daisuke Ogawa,Yoshinori Nishimoto,Yohei Okada,Yo Mabuchi,Takeshi Kawase,Akio Iwanami,Paul S. Mischel,Hideyuki Saya,Kazunari Yoshida,Yumi Matsuzaki,Hideyuki Okano	2012	74
13	Gene Targeting and Subsequent Site-Specific Transgenesis at the β- actin ( ACTB ) Locus in Common Marmoset Embryonic Stem Cells Seiji Shiozawa,Kenji Kawai,Yohei Okada,Ikuo Tomioka,Takuji Maeda,Akifumi Kanda,Haruka Shinohara,Hiroshi Suemizu,Hirotaka James Okano,(unknown),Yusuke Sotomaru,Erika Sasaki,(unknown),(unknown)	2010	20
14	Generating induced pluripotent stem cells from common marmoset (Callithrix jacchus) fetal liver cells using defined factors, including Lin28 Ikuo Tomioka,Takuji Maeda,Hiroko Shimada,Kenji Kawai,Yohei Okada,Hiroshi Igarashi,Ryo Oiwa,Tsuyoshi Iwasaki,Mikio Aoki,Tōru Kimura,Seiji Shiozawa,Haruka Shinohara,Hiroshi Suemizu,Erika Sasaki,Hideyuki Okano	2010	101
15	Roles of ES Cell-Derived Gliogenic Neural Stem/Progenitor Cells in Functional Recovery after Spinal Cord Injury Gentaro Kumagai,Yohei Okada,Junichi Yamane,Narihito Nagoshi,Kazuya Kitamura,Masahiko Mukaino,Osahiko Tsuji,Kanehiro Fujiyoshi,Hiroyuki Katoh,Seiji Okada,Shinsuke Shibata,Yumi Matsuzaki,Satoshi Toh,Yoshiaki Toyama,Masaya Nakamura,Hideyuki Okano	2009	97
16	Stromal cell‐secreted factors promote the survival of embryonic stem cell‐derived early neural stem/progenitor cells via the activation of MAPK and PI3K‐Akt pathways Seiji Ishii,Yohei Okada,Toshihiko Kadoya,Yumi Matsuzaki,Takuya Shimazaki,Hideyuki Okano	2009	23
17	Variation in the safety of induced pluripotent stem cell linesbreakdown → Kyoko Miura,Yohei Okada,Takashi Aoi,A. Okada,Kazutoshi Takahashi,Keisuke Okita,Masato Nakagawa,Michiyo Koyanagi,Koji Tanabe,Mari Ohnuki,Daisuke Ogawa,Eiji Ikeda,Hideyuki Okano,Shinya Yamanaka	2009	664
18	Ontogeny and Multipotency of Neural Crest-Derived Stem Cells in Mouse Bone Marrow, Dorsal Root Ganglia, and Whisker Pad Narihito Nagoshi,Shinsuke Shibata,Yoshiaki Kubota,Masaya Nakamura,Yasuo Nagai,Etsuko Satoh,Satoru Morikawa,Yohei Okada,Yo Mabuchi,Hiroyuki Katoh,Seiji Okada,Keiichi Fukuda,Toshio Suda,Yumi Matsuzaki,Yoshiaki Toyama,Hideyuki Okano	2008	291
19	Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells Yohei Okada,Takuya Shimazaki,Gen Sobue,Hideyuki Okano	2004	280
20	HMN-709, a Chlorobenzenesulfonamide Derivative, Is a New Membrane-Permeable Calmodulin Antagonist Hisayuki Yokokura,Yohei Okada,Osamu Terada,H Hidaka	1996	4

About Yohei Okada

Yohei Okada is a scholar working on Developmental Neuroscience, Genetics and Cellular and Molecular Neuroscience, having authored 69 papers that have together received 5.6k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (27 papers), Neurogenesis and neuroplasticity mechanisms (15 papers), CRISPR and Genetic Engineering (10 papers), Genetic Neurodegenerative Diseases (8 papers), Neurogenetic and Muscular Disorders Research (8 papers), Mesenchymal stem cell research (7 papers), RNA Research and Splicing (7 papers) and Muscle Physiology and Disorders (6 papers). The work is most often cited by research in Developmental Neuroscience (1.1k citations), Genetics (897 citations) and Cellular and Molecular Neuroscience (1.4k citations). Yohei Okada has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Hideyuki Okano, Shinya Yamanaka, Masaya Nakamura, Wado Akamatsu, Takuya Shimazaki, Gen Sobue, Satoshi Nori, Yoshiaki Toyama, Osahiko Tsuji and Kyoko Miura.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact